COMPANY PROFILE
ETHRIS GmbH
GmbH (Limited Liability Company)PlaneggResearch and experimental development on biotechnology
FOUNDED
2009
16+ years active
TRADE REGISTER
HRB 182200
München
INDUSTRY
Research and experimental development on biotechnology
SIZE CLASS
Medium-sized enterprise
Key questions answered
What does the company do?
Erforschung und Entwicklung von neuen Therapieverfahren und -produkten zur Behandlung erworbener und angeborener Erkrankungen sowie im Zusammenhang damit der Erwerb und die Vergabe von Lizenzen und Übernahme von Beratungs-, Handels- und Vertriebsaktivitäten.
Who leads it?
Christian Plank, and 2 more
How large is it?
Medium-sized enterprise · 59 employees (2023)
How stable is it?
Stability assessment in Plus profile
Business activity
Industry (WZ2008)
Research and experimental development on biotechnology
WZ M72.11
Size class
Medium
Industry (WZ2008) (3)
- M72.11Research and experimental development on biotechnology
- M72.19Other research and experimental development on natural sciences and engineering
- M74.90Other professional, scientific and technical activities n.e.c.
Business purpose
Erforschung und Entwicklung von neuen Therapieverfahren und -produkten zur Behandlung erworbener und angeborener Erkrankungen sowie im Zusammenhang damit der Erwerb und die Vergabe von Lizenzen und Übernahme von Beratungs-, Handels- und Vertriebsaktivitäten.
Legal essentials
- Register entry
- HRB 182200 (München)
- Legal form
- GmbH (Limited Liability Company)
- Founded
- 25 Oct 2009
- Share capital
- €101,579
- VAT ID
- —
- LEI
- 529900Z0RUGX6KU9I566
- Representation rules
- Ist nur ein Geschäftsführer bestellt, so vertritt er die Gesellschaft allein. Sind mehrere Geschäftsführer bestellt, so wird die Gesellschaft durch zwei Geschäftsführer oder durch einen Geschäftsführer gemeinsam mit einem Prokuristen vertreten.
Order shareholder list
The statutory shareholder list (§ 40 GmbHG) straight from the official register portal — who holds which shares.
Available in the Plus profile
Annual statements
- Balance sheet
- €16,735,180
- Year
- 2023
9 annual statements are on file for this company.
Signals
Four dimensions from hard data — age, financials, HRB events, compliance. The ratings themselves are shown in the Plus profile only.
- Continuity1Available in Plus profile
- Financials2Available in Plus profile
- Management3Available in Plus profile
- Legal status4Available in Plus profile
Directors & officers
Managing directors
Christian Plank
Managing Director
Carsten Rudolph
Managing Director
Christian Marco Wawrzinek
Managing Director
Research contacts
AI-powered research for publicly available contacts: name, role, phone, email, LinkedIn.
Available in the Plus profile
Recent news
AI-powered research across press, social media and job postings from the last six months.
Available in the Plus profile
Commercial register history
No events on file.
Companies with a similar profile
Creative Therapeutics GmbH
Wuppertal
Theranostik Pharma GmbH
Dresden
Future Therapeutics UG (haftungsbeschränkt)
Berlin
Future Therapeutics GmbH
Mainz
Venus & Eris GmbH
Bonn
Repeat Therapeutics GmbH
Mainz
HD Therapeutics GmbH
Ketsch
Thiele Engineering UG (haftungsbeschränkt)
Stahnsdorf
EXDRA GmbH
Grafing
ida GmbH
Pöcking
Location neighbours
DEVELOPERS
Programmatic access
Three ways to access this company's data programmatically:
- AGENT-CARD
Freely accessible, no API key required — a compact JSON summary for agents and crawlers.
- API
Full, authenticated data via the Implisense API v2 (API key required).
- MCP
MCP server live at mcp.implisense.com (FastMCP, Bearer auth) — usable with ChatGPT, Claude, and your own agents.
What the Plus profile adds
The same page, fully populated — plus the research services locked here.
- Revenue, result and equity across every available year
- All four signals with rationale and source
- Contact search: names, roles, phone, email, LinkedIn
- Shareholder list from the official register portal
- News research covering the last six months
- The full commercial register history